Delta Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.7K | Hold |
30
| – | – | ﹤0.01% | 498 |
|
|
2026
Q1 | $4.58K | Buy |
+30
| New | +$4.6K | ﹤0.01% | 498 |
|
|
2024
Q3 | – | Sell |
-25
| Closed | -$2.66K | – | 631 |
|
|
2024
Q2 | $2.66K | Hold |
25
| – | – | ﹤0.01% | 544 |
|
|
2024
Q1 | $2.42K | Hold |
25
| – | – | ﹤0.01% | 558 |
|
|
2023
Q4 | $2.52K | Hold |
25
| – | – | ﹤0.01% | 567 |
|
|
2023
Q3 | $2.55K | Hold |
25
| – | – | ﹤0.01% | 568 |
|
|
2023
Q2 | $2.52K | Hold |
25
| – | – | ﹤0.01% | 576 |
|
|
2023
Q1 | $2.3K | Hold |
25
| – | – | ﹤0.01% | 556 |
|
|
2022
Q4 | $2.27K | Buy |
+25
| New | +$2.11K | ﹤0.01% | 586 |
|
|
2022
Q1 | – | Sell |
-50
| Closed | -$4K | – | 431 |
|
|
2021
Q4 | $4K | Hold |
50
| – | – | ﹤0.01% | 558 |
|
|
2021
Q3 | $4K | Sell |
50
-75
| -60% | -$6.75K | ﹤0.01% | 555 |
|
|
2021
Q2 | $11K | Hold |
125
| – | – | ﹤0.01% | 451 |
|
|
2021
Q1 | $11K | Hold |
125
| – | – | ﹤0.01% | 432 |
|
|
2020
Q4 | $12K | Buy |
125
+75
| +150% | +$6.55K | ﹤0.01% | 409 |
|
|
2020
Q3 | $4K | Hold |
50
| – | – | ﹤0.01% | 503 |
|
|
2020
Q2 | $4K | Sell |
50
-125
| -71% | -$10.8K | ﹤0.01% | 514 |
|
|
2020
Q1 | $14K | Hold |
175
| – | – | ﹤0.01% | 353 |
|
|
2019
Q4 | $17K | Hold |
175
| – | – | ﹤0.01% | 365 |
|
|
2019
Q3 | $15K | Sell |
175
-50
| -22% | -$4.49K | ﹤0.01% | 373 |
|
|
2019
Q2 | $21K | Sell |
225
-26
| -10% | -$2.2K | ﹤0.01% | 305 |
|
|
2019
Q1 | $22K | Hold |
251
| – | – | ﹤0.01% | 293 |
|
|
2018
Q4 | $19K | Sell |
251
-140
| -36% | -$10.9K | ﹤0.01% | 342 |
|
|
2018
Q3 | $30K | Buy |
391
+335
| +598% | +$24.8K | ﹤0.01% | 308 |
|
|
2018
Q2 | $4K | Hold |
56
| – | – | ﹤0.01% | 553 |
|
|
2018
Q1 | $4K | Hold |
56
| – | – | ﹤0.01% | 549 |
|
|
2017
Q4 | $4K | Hold |
56
| – | – | ﹤0.01% | 536 |
|
|
2017
Q3 | $4K | Sell |
56
-40
| -42% | -$3.02K | ﹤0.01% | 510 |
|
|
2017
Q2 | $7K | Sell |
96
-37
| -28% | -$2.62K | ﹤0.01% | 450 |
|
|
2017
Q1 | $9K | Buy |
133
+37
| +39% | +$2.47K | ﹤0.01% | 432 |
|
|
2016
Q4 | $6K | Sell |
96
-3
| -3% | -$195 | ﹤0.01% | 484 |
|
|
2016
Q3 | $7K | Hold |
99
| – | – | ﹤0.01% | 450 |
|
|
2016
Q2 | $7K | Hold |
99
| – | – | ﹤0.01% | 446 |
|
|
2016
Q1 | $6K | Hold |
99
| – | – | ﹤0.01% | 458 |
|
|
2015
Q4 | $8K | Buy |
99
+40
| +68% | +$3.18K | ﹤0.01% | 432 |
|
|
2015
Q3 | $5K | Hold |
59
| – | – | ﹤0.01% | 476 |
|
|
2015
Q2 | $5K | Sell |
59
-88
| -60% | -$8.07K | ﹤0.01% | 495 |
|
|
2015
Q1 | $13K | Hold |
147
| – | – | ﹤0.01% | 389 |
|
|
2014
Q4 | $12K | Sell |
147
-112
| -43% | -$9.28K | ﹤0.01% | 404 |
|
|
2014
Q3 | $22K | Sell |
259
-61
| -19% | -$4.93K | ﹤0.01% | 330 |
|
|
2014
Q2 | $26K | Buy |
320
+195
| +156% | +$15.3K | 0.01% | 304 |
|
|
2014
Q1 | $10K | Sell |
125
-65
| -34% | -$4.74K | ﹤0.01% | 413 |
|
|
2013
Q4 | $14K | Hold |
190
| – | – | ﹤0.01% | 369 |
|
|
2013
Q3 | $13K | Buy |
190
+8
| +4% | +$529 | ﹤0.01% | 372 |
|
|
2013
Q2 | $12K | Buy |
+182
| New | +$11.8K | ﹤0.01% | 392 |
|
Other funds holding NVS
Delta Asset Management's NVS Position: Q2 2026 in Review
Delta Asset Management held its Novartis (NVS) position steady in Q2 2026 at 30 shares worth $4.7K. The position accounts for ﹤0.01% of the portfolio, ranked #498.
Delta Asset Management first reported a position in NVS in Q2 2013 and has held it in 44 quarters since. The position peaked at $30K in Q3 2018. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Delta Asset Management held 30 shares of Novartis worth $4.7K as of Q2 2026.
- Delta Asset Management left its Novartis share count unchanged in Q2 2026.
- Novartis made up ﹤0.01% of Delta Asset Management's portfolio in Q2 2026, its #498 holding.
- Delta Asset Management first reported a position in Novartis in Q2 2013 and has held it in 44 quarters since.
- Delta Asset Management's Novartis position peaked at $30K in Q3 2018.
- 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Delta Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.